(AMH/tT) achieved independent predictor status for sperm retrieval at microTESE, with a predictive accuracy of 93% and 95%, respectively. Using cutoff values of <4.62 ng/ml for AMH and <1.02 for AMH/tT, positive sperm retrieval was predicted in all individuals, with 19 men out of 47 potentially spared from surgery. DCA findings demonstrated clinical net benefit using AMH and AMH/tT for patient selection at microTESE.
INTRODUCTION AND OBJECTIVES: Long non-coding RNA's (lncRNA's) represent a heterogenous group of transcripts that are spliced, polyadenylated, and exhibit temporospatial regulation within the cell. Although they do not code for proteins, emerging evidence demonstrates that some lncRNA species harbor significant function. It is known that lncRNA expression is considerably higher within the testis as compared to other tissues. The role of these lncRNA's in male infertility, however, remains yet to be elucidated. To this end, we sought to characterize differential expression (DE) of lncRNA's within men demonstrating varying levels of spermatogenic arrest.
METHODS: Testis biopsies were obtained during testicular sperm extraction for infertility. Samples were snap frozen in liquid nitrogen for future processing. Total RNA was isolated from all testicular tissues using miRCURY RNA Isolation Kit (Exiqon). Eluted total RNA was checked for purity and integrity on an Agilent Bioanalyzer 2100 (Agilent Technologies, CA, USA). Non-stranded RNA-seq libraries were prepared (TRUseq, Illumina) and sequenced on an Illumina HiSeq 2000 platform. The RNA was sequenced in bulk and mapped using the STAR Aligner v2.5 against human genome hg38. Raw counts were normalized with Limma v3.6 using the R statistical package v3.4.
RESULTS: A total of 54 biopsies were procured from men with infertility with histopathologic diagnoses consisting of: 7 Klinefelter syndrome, 11 Sertoli-cell only syndrome (SCO), 11 early maturation arrest (EMA), 5 late maturation arrest (LMA), 10 hypospermatogenesis (HY), and 10 normal (NL). We focused our analysis on long-intergenic lncRNA's, of which we mapped 939 unique transcripts. The number of statistically significant (p < 0.05) lncRNA's with DE (|DE| >¼ 2x) for SCO vs EMA, EMA vs LMA, LMA vs HY, and HY vs NL was 361, 11, 291, and 603, respectively. The genes with greatest |DE| and a high number of transcripts per cell were LINC01206, LINC02349, LINC02204, and LINC00473 for SCO vs EMA, EMA VS LMA, LMA vs HY, and HY vs NL, respectively.
CONCLUSIONS: A large number of non-coding transcripts are expressed in both normal and diseased testicular tissue. Considerable DE exists among long-intergenic lncRNA's when comparing pathologies representing various stages of spermatogenic arrest. Further study of these transcripts regarding their function, and possible contribution to male infertility, is warranted. 
INTRODUCTION AND OBJECTIVES:
The etiology of nonobstructive azoospermia (NOA) is largely unknown and it is unclear if defects exist in somatic cell regulation or is due to abnormal germ cells. In this study, we wished to evaluate differences in expression of key spermatogonial (SPG) regulatory genes among different NOA phenotypes.
METHODS: Testis tissue from 54 patients with non-obstructive azoospermia (NOA): Sertoli Cell Only (SCO), early and late maturation arrest (eMA, lMA), hypospermatogeneis (HS), Klinefelter Syndrome (KS) and normal controls (NL) were included. RNA libraries were sequenced on an Illumina HiSeq 2000 platform. To address cellular heterogeneity, we normalized the SPG genes to SOX9 expression as the number of Sertoli cells per tubule was assumed to be stable between samples; Figure 1 , demonstrates stable expression of SOX9 (Sertoli Cell), ID4, SALL4 (Spermatogonia) between SCO and NL, while NLs demonstrate significant increase in SYCP3 (spermatocyte) and TNP1 (spermatid) as expected.
RESULTS: 21,879 transcripts were mapped to the genome. Using a multivariate cluster analysis, we identified the first hierarchical division of most highly expressed SPG markers in NLs. This cluster included ITGA6, ID4, UCHL1 and SOHLH1; each are genes expressed in spermatogonial stem cells (SSCs) aside from SOHLH1, which is a marker in differentiating SPG. Second order divisions included SOHLH2, UTF1, KIT, ENO2, THY1, and a second cluster of PAX7, NEUROG3, CDH1, OCT4, STRA8, GFRA1, BCL6B, SALL4, ZBTB16, SOX2, and SOX3. Conversely, among SCO, ID4 and ITGA6 remained in the first hierarchal branch while UCHL1 and SOHLH1 were at much lower expression. ID4, ITGA6, NEUROG3, SALL4 and THY1 were the only markers not significantly different between SCO and all other phenotypes. Among eMA, SALL4 expression was significantly lower compared to NL (p¼0.001). Among KS, SOX3 (p¼0.001) was the only marker decreased compared to NL, suggesting SPG markers are relatively normal despite SCO histology and thus, may point towards somatic cell dysfunction.
CONCLUSIONS: This study has identified the relationship of SPG markers within NL tissue, as well as within and between NOA histological classes. This provides an initial step in characterizing the lineage and active pathways of SSCs among men with NOA. This insight is critical to assessing the contribution of aberrant SPG regulation in the mechanisms of failed spermatogenesis.
